$XENE has been mentioned 5 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on 2025-12-19 and the most recent on 2026-07-01. Adam Feuerstein (@adamfeuerstein) accounts for 4 of these mentions, establishing himself as the most active voice discussing Xenon Pharmaceuticals. The biotech sector category dominates discussion of this ticker. Xenon Pharmaceuticals operates in the neurology and epilepsy treatment space, with recent activity centered on clinical trial data released in March 2026.